| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 354,097 | 350,489 | 351,910 | 433,022 | | Cost of Revenue | 195,144 | 189,470 | 188,111 | 228,948 | | | Gross Profit | 158,953 | 161,019 | 163,799 | 204,074 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 117,146 | 115,778 | 120,557 | 129,646 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 41,807 | 45,241 | 43,242 | 74,428 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 97 | 229 | 208 | 317 | | Earnings Before Interest And Taxes | 41,904 | 45,470 | 43,450 | 74,745 | | Interest Expense | 417 | 544 | 774 | 1,894 | | Income Before Tax | 41,487 | 44,926 | 42,676 | 72,851 | | Income Tax Expense | 15,493 | 17,171 | 16,398 | 27,756 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 25,994 | 27,755 | 26,278 | 45,095 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,994 | 27,755 | 26,278 | 45,095 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $25,994 | $27,755 | $26,278 | $45,095 |
|
0.29% Nasdaq 
Income Statement
